Torrent Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Torrent Pharmaceuticals Ltd. on BSE

Load latest

Torrent Pharmaceuticals Ltd.

30 May 2023

3731.10

-0.98%

Corp. Note

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Dividend Updates

BSE India

Board Recommended to the members a final dividend of ? 8/- (160%) per equity share of ? 5 each. The final dividend amount, if declared by the Shareholders, is proposed to be paid / dispatched on or around 14th August, 2023. Earlier an interim dividend of ? 14/- (280%) per equity share was paid during the last quarter.

pdf

Torrent Pharmaceuticals Ltd.

30 May 2023

3731.10

-0.98%

Board Meeting

TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Outcome for Disclosure Pursuant To Regulation 30 Read …

BSE India

Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")

pdf

Torrent Pharmaceuticals Ltd.

30 May 2023

3731.10

-0.98%

Result

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Pursuant To Regulation 30 Read With Schedule III And …

BSE India

Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")

pdf

Torrent Pharmaceuticals Ltd.

30 May 2023, 12:00AM

3731.10

-0.98%

Annual Report

Annual report for Torrent Pharmaceuticals Ltd. for FY-2023

None

pdf

Torrent Pharmaceuticals Ltd.

25 May 2023

3731.10

-0.98%

Company Update

TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Torrent Pharmaceuticals Ltd.

24 May 2023

3731.10

-0.98%

Company Update

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to Regulation 24A(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 08-Feb-19 and BSE and NSE Circulars dated 16-Mar-23 and 10-Apr-23 respectively, kindly find enclosed herewith Annual Secretarial Compliance Report for the year ended on 31-Mar-23 issued by M/s. M. C. Gupta & Co., Practicing Company Secretaries, Ahmedabad. Kindly take note of the above.

pdf

Torrent Pharmaceuticals Ltd.

18 May 2023

3731.10

-0.98%

Company Update

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

We would like to inform that Hon''ble National Company Law Tribunal, Ahmedabad Bench ("NCLT"), vide its Order dated 17th May, 2023, has sanctioned the Scheme of Arrangement in the nature of Amalgamation between Curatio Health Care (I) Private Limited, a wholly owned subsidiary of the Company with Torrent Pharmaceuticals Limited and their respective shareholders and creditors ("Scheme") pursuant to the provisions of Section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules made thereunder. A copy of the said Order is available on the website of the Company. The above is in continuation to our earlier communication dated 21-Dec-22 intimating the approval of the said Scheme of Amalgamation by the Board of Directors of the Company in its meeting held on 21-Dec-22. The Scheme will become effective upon filing of the said Order with the Registrar of Companies, Gujarat. Kindly take note of the above.

pdf

Torrent Pharmaceuticals Ltd.

16 May 2023

3731.10

-0.98%

Company Update

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Post Quarterly Financial Result Conference call with investors / analyst We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 30th May, 2023 at 06:00 P.M. to discuss the financial performance of the Company for the quarter and year ended 31st March, 2023.

pdf

Torrent Pharmaceuticals Ltd.

16 May 2023

3731.10

-0.98%

Board Meeting

TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board …

BSE India

TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve We would like to inform you that: 1. A meeting of the Board of Directors will be held on Tuesday, 30-May-23, inter alia, to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-23. 2. In the above meeting, the Board would also consider the following: i. Recommendation of final dividend, if any, on the equity shares of the Company, for the year 2022-23. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders'' approval in the ensuing Annual General Meeting. Kindly take note of the above.

pdf

Torrent Pharmaceuticals Ltd.

26 Apr 2023

3731.10

-0.98%

Corp. Note

TORRENT PHARMACEUTICALS LTD. - 500420 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company TORRENT PHARMACEUTICALS LTD. 2 CIN NO. L24230GJ1972PLC002126 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2022-23, 2023-24, 2024-25 5 Incremental borrowing done in FY (T)(a) 1395.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 348.75 7 Actual borrowing done through debt securities in FY (T)(c) 500.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NIL 8Quantum of (d), which has been met from (c)(e)* NA 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NIL Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2021-22, 2022-23, 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Chintan M TrivediDesignation :-Company Secretary Name of the Chief Financial Officer :- Sudhir Menon Designation : -Chief Financial Officer Date: 26/04/2023

pdf

Is Torrent Pharmaceuticals Ltd. worth buying?

150 Votes:

Buy 74.67%

Sell 16.67%

Hold 8.67%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf